Home › Funds › PFIZER INC › ZURA
PFIZER INC position in ZURA
Zura Bio Ltd · Health Care
PFIZER INC reported holding 538,841 shares of ZURA (Zura Bio Ltd) in its Q3 2026 13F filing — a position valued at US$2.2M, representing 1.33% of its reported portfolio and ranking #13 among its reported holdings. PFIZER INC has disclosed ZURA holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How PFIZER INC's ZURA position evolved
PFIZER INC first disclosed a stake in ZURA in Q4 2024 at 2,970,022 shares (US$7.4M). The position peaked in Q1 2026 at 2,838,913 shares, worth US$16.8M. Across 8 filings, PFIZER INC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 538,841 shares valued at US$2.2M. Notable position changes include a 81% trim in Q2 2026 (shares fell 29% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 2.97M | $7.43M | New |
| Q1 2025 | 2.97M | $3.83M | Hold |
| Q2 2025 | 2.97M | $3.12M | Hold |
| Q3 2025 | 2.97M | $12.86M | Hold |
| Q4 2025 | 2.97M | $15.56M | Hold |
| Q1 2026 | 2.84M | $16.83M | Reduce |
| Q2 2026 | 538.84K | $2.88M | Reduce |
| Q3 2026 | 538.84K | $2.18M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZURA and 13F data
ZURA (Zura Bio Ltd) is a Health Care company. 51 other funds we track also report a position in ZURA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$55.7M), Venrock Adviser, LLC (US$38.0M), MPM BioImpact LLC (US$26.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZURA
- MONTANOVA CAPITAL, LLC 9.44M sh · $55.71M · Q2 2026
- Venrock Adviser, LLC 6.43M sh · $37.97M · Q2 2026
- MPM BioImpact LLC 4.47M sh · $26.39M · Q2 2026
- GREAT POINT PARTNERS LLC 4.22M sh · $24.87M · Q2 2026
- BRAIDWELL LP 3.98M sh · $23.48M · Q2 2026
- Commodore Capital LP 3.25M sh · $19.18M · Q2 2026
- Saturn V Capital Management LP 2.10M sh · $12.40M · Q2 2026
- QVT Financial LP 1.90M sh · $11.18M · Q2 2026
- ADAR1 Capital Management, LLC 1.76M sh · $10.38M · Q2 2026
- STEMPOINT CAPITAL LP 1.37M sh · $8.07M · Q2 2026
- Ikarian Capital, LLC 1.22M sh · $7.19M · Q2 2026
- EcoR1 Capital, LLC 1.18M sh · $6.96M · Q2 2026
More on PFIZER INC
FAQ
How long has PFIZER INC held ZURA?
PFIZER INC has disclosed ZURA holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is PFIZER INC's current position in ZURA?
As of Q3 2026, PFIZER INC holds 538.84K shares of ZURA (Zura Bio Ltd), valued at $2.18M, representing 1.33% of its reported portfolio and ranking #13.
Has PFIZER INC been buying or selling ZURA?
In the latest 13F filing (Q3 2026), PFIZER INC held unchanged its position in ZURA. The position peaked in Q1 2026 at 2.84M shares.
Which other funds hold ZURA?
Other major institutional holders of ZURA include MONTANOVA CAPITAL, LLC, Venrock Adviser, LLC, MPM BioImpact LLC, among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.